Tatsuya Fukuda

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Venues

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Clinical and experimental nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Tatsuya Fukuda, Akiko Fujii, Taro Akihisa, Naoya Otsubo, Masanori Murakami, Tetsuya Yamada, Chisato Maki
Association between Diabetic Peripheral Neuropathy as Measured Using a Point-of-Care Sural Nerve Conduction Device and Urinary Albumin Excretion in Patients with Type 2 Diabetes. Journal of clinical medicine 12 (12) (2023)
Hiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, Tomoko Kawanishi, Toshie Ogawa, Yasutomo Abe, Mariko Endo, Tomohide Hanawa, Chise Sugita, Yoshiaki Kikkawa, Shuji Hatakeyama, Tetsuya Yamada, Sachiko Wakai
Serum Chemokine CC-motif ligand 17 is a predictive marker of severe COVID-19 in hemodialysis patients: a retrospective observational study. Nephrology (Carlton, Vic.) (2023)
Hiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, Tomoko Kawanishi, Toshie Ogawa, Yasutomo Abe, Mariko Endo, Tomohide Hanawa, Chise Sugita, Yoshiaki Kikkawa, Shuji Hatakeyama, Tetsuya Yamada, Sachiko Wakai
Serum chemokine CC-motif ligand 17 is a predictive marker of severe COVID-19 in haemodialysis patients: A retrospective observational study. Nephrology (Carlton, Vic.) (2023)
Hiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, Tomoko Kawanishi, Toshie Ogawa, Yasutomo Abe, Mariko Endo, Tomohide Hanawa, Chise Sugita, Yoshiaki Kikkawa, Shuji Hatakeyama, Tetsuya Yamada, Sachiko Wakai
Serum chemokine CC-motif ligand 17 is a predictive marker of severe COVID-19 in haemodialysis patients: A retrospective observational study. Nephrology (Carlton, Vic.) 28 (4) (2023)
Hiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, Taro Akihisa, Tomoko Kawanishi, Toshie Ogawa, Yasutomo Abe, Mariko Endo, Tomohide Hanawa, Chise Sugita, Yoshiaki Kikkawa, Tetsuya Yamada, Sachiko Wakai
Comparative outcomes of hemodialysis patients facing pre-Omicron and Omicron COVID-19 epidemics. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2023)
Hiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, Tomoko Kawanishi, Toshie Ogawa, Yasutomo Abe, Mariko Endo, Tomohide Hanawa, Chise Sugita, Yoshiaki Kikkawa, Shuji Hatakeyama, Tetsuya Yamada, Sachiko Wakai
Serum chemokine CC-motif ligand 17 is a predictive marker of severe COVID-19 in haemodialysis patients: A retrospective observational study. Nephrology (Carlton, Vic.) 28 (4) (2023)
Tatsuya Fukuda, Akiko Fujii, Taro Akihisa, Naoya Otsubo, Masanori Murakami, Tetsuya Yamada, Chisato Maki
Association between Diabetic Peripheral Neuropathy as Measured Using a Point-of-Care Sural Nerve Conduction Device and Urinary Albumin Excretion in Patients with Type 2 Diabetes. Journal of clinical medicine 12 (12) (2023)
Tatsuya Fukuda
Special Issue "Clinical Epidemiology of Diabetes and Its Complications". Journal of clinical medicine 11 (15) (2022)
Hiroko Beppu, Tatsuya Fukuda, Tomoko Kawanishi, Fumihiko Yasui, Minami Toda, Hitomi Kimura, Yuki Nakamura, Yuka Nakamura, Kaori Kojima, Hina Ogawa, Ayumi Ishiwatari, Yuiko Kamei, Toshie Ogawa, Yasutomo Abe, Mariko Endo, Tomohide Hanawa, Rie Mizobuchi, Chise Sugita, Koh Okamoto, Shuji Hatakeyama, Tetsusya Yamada, Michinori Kohara, Sachiko Wakai
Hemodialysis patients with coronavirus disease 2019: reduced antibody response. Clinical and experimental nephrology (2021)

Tatsuya Fukuda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tatsuya Fukuda